| February 22, 2012 | News for the transfusion medicine and cellular therapy community |
 |  |
| Top Story |  |  |
|
| Science & Health | | |
|
- Study: Transplant patients may be more susceptible to skin cancer
Patients who have received a solid organ transplant might be at higher risk for aggressive skin cancers of the head and neck, a study at Detroit's Henry Ford Hospital found. Researchers studied the records of 3,639 patients who had received a solid organ transplant from 1990 through 2011. Though the overall incidence was low, the skin cancers that did occur tended to be aggressive and were associated with shorter survival times, the researchers said. "We believe these patients require aggressive screening, treatment and follow-up," the study's leader said. SkinAndAllergyNews.com
(2/16)     
- Some hospitals do social media better than others
Many hospitals have a social media presence, with Facebook pages, Twitter accounts and YouTube channels, but some do it better than others, writes Arundhati Parmar. Successful Facebook pages engage users with multimedia offerings and opportunities to take action, while others are static and dull, Parmar writes. MedCityNews.com
(2/20)
|
|
HANDS ON STEM CELL TRAINING.
Learn how to grow stem cells and perform quality control testing following FDA regulations in a cGMP facility. Learn from established experts in the field. Courses held at BioHeart, Inc. labs in collaboration with the Ageless Regenerative Institute. Learn More. |
| Industry News & Practice | | |
|
| Government & Regulatory | | |
|
| Association News | | |
|
-
AABB website inaccessible this week and undergoing scheduled maintenance
The AABB website will be inaccessible and undergoing scheduled maintenance from 7 p.m. EST Friday, Feb. 24, through 8:30 a.m. EST Monday, Feb. 27. The association apologizes for the inconvenience and encourages those in need of assistance to contact AABB Membership Services via e-mail.
| SmartQuote | | |
|
 | Truth, like gold, is to be obtained not by its growth, but by washing away from it all that is not gold."
--Leo Tolstoy,
Russian writer
|
| |
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AABB SmartBrief Issues:
- Tuesday, February 21, 2012
- Monday, February 20, 2012
- Friday, February 17, 2012
- Thursday, February 16, 2012
- Wednesday, February 15, 2012
| | | Lead Editor: Tom Parks
Managing Editor: Aaron Lyss
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2012 SmartBrief, Inc.® Legal Information |
|
More information is needed to determine the right time to stop dual-antiplatelet therapy after drug-eluting stent implantation, according to a presentation at the Cardiovascular Research Technologies meeting. The practice varies, but current guidelines recommend 12 months of treatment. 
